Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allograft and Nonalcoholic Steatohepatitis.

The pressing need for available organs is growing as the field of liver transplantation evolves and responds with expanding criteria and utilization of marginal allografts for certain recipients (1). Over the past 15 years, patient and graft outcomes of marginal allografts including donation after cardiac death, advanced age donors, and macrosteatoic allograft have improved (2). Altshuler and colleagues contribute further to clinically useful insights into increased organ availability utilizing macrosteatotic allografts in recipients with nonalcoholic steatohepatitis (NASH) cirrhosis (1).